General discussion, page-4433

Anyone has a valid reason not to go all on this stock.
I consider this share to be low risk with high potential for many reasons, would love your thoughts
great management
excited holders, it is rare to have an excited community like the holder of IHL
all targeted conditions are backed by strong body of research
all targeted cases has no evidence existing medicine, which make it much easier to get FDA approval, that’s what GW did
US listing is expected to 400% plus in 6 months ( conservative estimate, the same has happened to to MXC and others
when you take to US investors about Cannabies, potential Covid treatment and magic mashroom they would only buy

the main risk I see is one of the trials to return negative results, the same has happened to GW , you need only one FDA approval not all your f them

would love to hear your thoughts